Silver Book Fact

Catheter ablation reduces risk of stroke and death among AFib patients

Atrial fibrillation patients who underwent catheter ablation had a reduced risk of stroke and death—2.2% of those who had ablation experienced stroke versus 4.7% on medications alone, and 6% died from stroke versus 23.5% of those on medications alone.

Day J, Crandall B, Osborn J, Weiss J, et al. Atrial Fibrillation Ablation Significantly Reduces Long-Term Mortality and Strokes in a Large Patient Population; 2010. https://www.heartrhythmjournal.com/issue/S1547-5271(10)X0004-2

Reference

Title
Atrial Fibrillation Ablation Significantly Reduces Long-Term Mortality and Strokes in a Large Patient Population
Publication
Heart Rhythm 2010: 31st Annual Scientific Sessions of the Heart Rhythm Society
Publication Date
2010
Authors
Day J, Crandall B, Osborn J, Weiss J, et al.
Volume & Issue
Volume 7, Issue 5
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Effectiveness of pacemaker/defibrillators to control AFib
    Widespread use of pacemaker/defibrillators to control atrial fibrillation could result in a 50% decrease in stroke.  
  • Atrial fibrillation ablation prevents recurrence of AFib
    Atrial fibrillation ablation, which involves using a catheter inserted into the heart to destroy electrical conduction tissue in or near the atria, prevents the recurrence of atrial fibrillation in up…  
  • Decrease in AFib hospitalization rates
    The use of practice guidelines in atrial fibrillation patients saw a decrease in rate of hospitalization from 74%to 38%.  
  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.  
  • Identifying individuals at high risk for developing AFib
    Using simple bedside measures, identification of individuals at risk for developing atrial fibrillation is feasible. Selecting high-risk individuals for inclusion in atrial fibrillation prevention trials may also enhance prevention strategies.